Annual Long Term Debt
$56.22 M
NaN%
December 31, 2022
Summary
- As of February 8, 2025, EGRX annual long term debt is $56.22 million
- During the last 3 years, EGRX annual long term debt has risen by +$19.66 million (+53.78%).
- EGRX annual long term debt is now at all-time high.
Performance
EGRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$61.90 M
-$6.93 M-10.07%
June 30, 2023
Summary
- As of February 8, 2025, EGRX quarterly long term debt is $61.90 million, with the most recent change of -$6.93 million (-10.07%) on June 30, 2023.
- Over the past year, EGRX quarterly long term debt has increased by +$31.62 million (+104.45%).
- EGRX quarterly long term debt is now -10.07% below its all-time high of $68.83 million, reached on March 31, 2023.
Performance
EGRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
EGRX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +104.5% |
| 3 y3 years | +53.8% | +91.9% |
| 5 y5 years | +31.0% | +53.0% |
EGRX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -10.1% | +2315.0% |
| 5 y | 5-year | at high | +123.7% | -10.1% | +2315.0% |
| alltime | all time | at high | +123.7% | -10.1% | +2315.0% |
Eagle Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $61.90 M(-10.1%) |
| Mar 2023 | - | $68.83 M(+22.4%) |
| Dec 2022 | $56.22 M(+123.7%) | $56.22 M(+98.6%) |
| Sep 2022 | - | $28.30 M(-6.5%) |
| Jun 2022 | - | $30.27 M(+1081.2%) |
| Mar 2022 | - | $2.56 M(-88.6%) |
| Sep 2021 | - | $22.54 M(-8.9%) |
| Jun 2021 | - | $24.73 M(-8.1%) |
| Mar 2021 | - | $26.92 M(+7.1%) |
| Dec 2020 | $25.14 M | $25.14 M(-15.8%) |
| Sep 2020 | - | $29.86 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $32.26 M(-5.8%) |
| Mar 2020 | - | $34.23 M(-6.4%) |
| Dec 2019 | $36.56 M(-4.2%) | $36.56 M(-6.1%) |
| Sep 2019 | - | $38.91 M(+4.0%) |
| Jun 2019 | - | $37.40 M(+1.1%) |
| Mar 2019 | - | $37.00 M(-3.0%) |
| Dec 2018 | $38.16 M(-11.1%) | $38.16 M(-2.9%) |
| Sep 2018 | - | $39.31 M(-2.9%) |
| Jun 2018 | - | $40.47 M(-2.8%) |
| Mar 2018 | - | $41.62 M(-3.0%) |
| Dec 2017 | $42.91 M | $42.91 M(-2.3%) |
| Sep 2017 | - | $43.94 M |
FAQ
- What is Eagle Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly long term debt year-on-year change?
What is Eagle Pharmaceuticals annual long term debt?
The current annual long term debt of EGRX is $56.22 M
What is the all time high annual long term debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual long term debt is $56.22 M
What is Eagle Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of EGRX is $61.90 M
What is the all time high quarterly long term debt for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly long term debt is $68.83 M
What is Eagle Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, EGRX quarterly long term debt has changed by +$31.62 M (+104.45%)